NCT00695084
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
Clinical trial condition
Multiple Sclerosis
Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
2,007 public trials
296 recruiting studies
Multiple Sclerosis trial results
NCT00037947
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- VA Medical Center Portland, Oregon, United States
NCT00529581
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognition Disorders, +8 more
- Locations
-
- Saint Joseph's Hospital, Barrow Neurology Clinics Phoenix, Arizona, United States
- Northwest Neuro Specialists, PLLC Tuscon, Arizona, United States
- Research Center for Clinical Studies West Lancaster, California, United States
- Loma Linda University, Department of Neurology Loma Linda, California, United States
Completed
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
NCT00501696
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- MS Center UCSF, Parnassus Ave, suite #908 San Francisco, California, United States
Completed
Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
NCT00103974
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Barrow Neurology Clinics Phoenix, Arizona, United States
- USC, LAC & USC Medical Center Los Angeles, California, United States
- University of British Columbia, MS Research Vancouver, British Columbia, Canada
- Montreal Neurological Institute, Clinical Research Unit and MS clinic Montreal, Quebec, Canada
NCT00644904
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- St. Michael's Hospital Toronto, Ontario, Canada
NCT00079495
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
- Locations
-
Not specified
NCT00146068
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- University of North Carolina-Chapel Hill MS clinic within the Neuroscience Hospital Chapel Hill, North Carolina, United States
Completed
Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)
NCT00001781
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States